Gilead Sciences faces a new dilemma in deciding how much it ought to profit from the only treatment thus far confirmed to help sufferers infected…
Posts tagged as “remdesivir”
Gilead Sciences’ shares soared 16% in after-hours trading Thursday following a media report detailing encouraging partial data from trials of the U.S. firm’s experimental drug remdesivir…